How to apply

There’s a common path that every Ben Franklin company follows toward investment.

It’s a tested approach that helps build your business, supports the confidence of potential investors, and introduces your vision to the many potential partners, capital sources, mentors, clients, and allies within our Circle of BENefits.

We're ready to start the conversation if your company:


Is a technology-focused business located in or with significant business presence in Philadelphia, Bucks, Chester, Delaware, or Montgomery counties


Can prove substantial technological differentiation with strong growth potential, sound corporate governance, and financial management


Can match Ben Franklin’s investment with capital from other sources—with funding from other investors, VCs, grants, friends and family, or other sources

Typical Investment Process

We focus on three sector-specific disciplines: IT, Healthcare, and Physical Sciences.


Our Investment Professionals

Health Review Committee

Farrokh Abadi
Social Venture Circle

Aditi U. Joshi, MD, MSC
Thomas Jefferson University

Akshara Reddy, MBA

Barthalomew Sillah, MD, MBA
Kola Global

Bill Bosch, Ph.D.
Botanix Pharmaceuticals

David Wierz, MA-ABD
The OCI Group, LLC

Donna Cordner
OKM Capital

Greg DiRusso, MD, FACS

Karen Roggeman, MBA
KJR Advisory, LLC

John Patrick Dougherty, MBA
WindMIL Therapeutics

Larissa Milne
Life Science Venture Consultant

Scott Fishman

Aaron Goldmuntz, MBA
Center for Medical Interoperability

Jim Gunton
Tech Council Ventures

Kate Hermans
Hermans International

Shanu Kohli Kurd, MD, MSCE, MHS
A&K Spinal Instruments

Jeffrey Martini, Ph.D.
Marinus Pharma

Sandy Matalonis, MBA
Independent Pharmaceutical and Biotech Consultant

Robert B. McGrath, Ph.D.
Drexel University

John Moran
RobinHood Ventures

Thomas A. Olenzak

Banu Onaral, Ph.D.
Drexel University

A. Sami Saribas, Ph.D.
Temple University

Stuart Segal
Behavioral Health Executive​

Allan Shatzman, Ph.D.
Pharmaceutical and Biotechnology Industry Expert

Catherine Angell Sohn, Pharm.D.
Sohn Health Strategie

Eric Sugalski, MBA

Rena Rosenberg, Ph.D.
Robin Hood Ventures

Gretchen L. Temeles, JD, Ph.D.
Duane Morris, LLP

Catherine Unruh
Medical Synergy and Innovation, Inc.

Samuel Edland, MS

Todd M. Wallach, MBA, MSE

Information Technology (IT)

Our Investment Professionals

Information Technology Review Committee

Brandi Baldwin, Ed.D.
Millennial Ventures Holding Co.

Philip Bronner
Ardent Venture Capital

Ryan Caplan

Eric Chapman

Bob Ciaruffoli
Baker Tilly Capital

Serhad Doken

Sean Dowling
Osage Venture Partners

Holly Flanagan
Gabriel Investments

Frederik Groce
Storm Ventures

Lori Hardwick
Advisors Innovations Labs

Joseph Herbst
Innovative Financing Solutions

Kevin Kemmerer
Dude Solutions

Dave Kurtz
KMS Capital Group

Shoshana K Loeb, Ph.D.
Open Ventures

Kevin Marc Leonard

Amul Mago
Amazon Web Services

Mark A. Mitchell
Pennswood Capital

Philip Moyer

David Nevas
Edison Partners

Katherine O’Neill
Jumpstart NJ Angel Network

Mark Mitchell
Delaware Crossing

Jordan DiPietro
Motley Fool

Pardon Makumbe
CRE Venture Capital

David Oppenheimer
Robin Hood Ventures

Doc Parghi
SRI Capital

Travis Pierce

Sushma Rajagopalan
Rittenhouse Ventures

Tom Rowinski
JTR Solutions

Neal Shah
InterDigital Communications

Evan Solomon
EFS Networks, Inc.

Nate Bomberger
Najabu Technologies

Leonid Kravets
InterDigital Communications

Jayson Tischler
Waterfall Advisory LLC

Neill Wright
Bronze Valley

Physical Sciences

Our Investment Professionals

PS Investment Advisory Committee (IAC)

David Achey
The Horton Fund

Stephen J. Albert, CFA
Capital Partners Consulting

Kip Anthony
EFE Laboratories

Michael A. Blaustein, Ph.D.
University of Delaware

Alain F. Bouruet Aubertot
Brane Capital

Brian k. Brady
Integritatem Capital Group

Frank J. Campanale
EFE Laboratories

William Collins
William Wallace Collins, LLC

Colleen Connors

Hal Craig
Trout Creek Consulting, LLC

Thomas P. Dwyer
Pepper Hamilton

Steve N. Economou
Baker Tilly Capital

Thomas Edwards
Temple University

Hanan Fishman
Alencon Systems

Glen D. Gaddy, Ph.D.
Robin Hood Ventures

Chad Gottesman

Andrew Hamilton, Esq.
Morgan, Lewis & Bockius LLP

Ian Harris
GMT Venture Partners, LLC

Harvey Z Hoffman
HZH Strategy

Skelly Holmbeck
Water Resources Association of the Delaware River Basin

Arthur L. Hudson
Rapid Markets

Stephen J. Kelly
The Kelly Group

Dawn Kerner
Volpe and Koenig

Andrea Kind
O3 World

Vipon Kumar
NextGen Sourcing

Gerard Leimkuhler
Berwyn Capital

Cheryl Martin
Harwich Partners

Donald P. Millstein
H20 Degree

Mark Mitchell
Delaware Crossing

James Murdock
Endless Pools

Anthony B. Parisi
Integrated Capital and Consulting

Pamela Raitt
Bellatrix Group

Patricia Woody Reeves
President & Founder of PWR Consulting Group

Karen Robinson
Geneva Global

Kimberly Saxton

Renee Selman
Agile Therapeutics

Robert F. Small, CPA
Robert Small & Associates, LLC

Karina Sotnik
WorldUpStart, LLC

Stephen Spivak
The Wearables Store

Steve Talis
Polysolutions Advisors

Alexis Werner
Bunker Labs

Leigh Wood
Social Venture Circle

Michael Yecies
MY Advisory Services

PS Technology Advisory Committee (TAC)

Marc Besser, Ph.D.
Penn State – Abington

Daryl S. Boudreaux, Ph.D.
Boudreaux & Associates

Steven Freilich, Ph.D.
Delaware Valley Materials for Energy Consortium

Arthur L. Hudson
Rapid Circuits

William Kane, Ph.D.
Exponent, Inc.

Karl M. Kraus
Material Growth Partners

Todor Raykov

William A. Roberts
Rolite, Inc.

Brett Rosen

Jorge Santiago, Ph.D.
University of Pennsylvania

Pritpal Singh, Ph.D.
Villanova University

Daniele S. Tedesco

Som Tyagi, Ph.D.
Drexel University

Kevin Wong
Emergent Energy Solutions

Please join us at one of our upcoming Meet Ben sessions to learn more.

Every business shapes its own unique path. However, key milestones will include the following sequence of touchpoints. As a Ben Franklin portfolio company, your path to investment will include opportunities to:

  • Build relationships with sector-focused members of our investment group.
  • Present to industry-specific subject matter experts in one to two rounds as part of your interactions with our executive review committee.
  • Gain knowledge of your business from our best-in-class due diligence process, with support from a third-party portfolio manager.
  • Be reviewed and approved by our full investment group, executive team, and board of directors.

Is your business ready to BENefit? Let’s talk.